Bicara Therapeutics Inc. (BCAX)
NASDAQ:BCAX
Want to see BCAX full AI Analyst Report?
Bicara Therapeutics Inc. (BCAX) Ownership Overview
21.76% Insiders
13.32% Mutual Funds
24.51% Other Institutional Investors
7.71% ETFs
32.70% Public Companies and
Individual Investors
The ownership structure of Bicara Therapeutics Inc. (BCAX) stock is a mix of institutional, retail, and individual investors. Approximately 45.54% of the company’s stock is owned by Institutional Investors, 21.76% is owned by Insiders, and 32.70% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Mar 02, 2026 | xxxxxxxxxxxxx | $4800000 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Sep 30, 2024 | xxxxxxxxxxxxx | $144321701 | |
Sep 30, 2024 | xxxxxxxxxxxxx | $47579864 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,255,993 | Institution | 11.04% | 151,214,894 | |
| 7,255,993 | Insider | 11.04% | 151,214,894 | |
| 6,281,185 | Insider | 9.56% | 130,899,895 | |
| 2,392,150 | Institution | 3.64% | 49,852,406 | |
| 2,018,702 | Institution | 3.07% | 42,069,750 | |
| 1,656,881 | Institution | 2.52% | 34,529,400 | |
| 1,428,006 | Institution | 2.17% | 29,759,645 | |
| 1,414,538 | Institution | 2.15% | 29,478,972 | |
| 1,224,336 | Institution | 1.86% | 25,515,162 | |
| 944,900 | Institution | 1.44% | 19,691,716 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,656,881 | Institution | 2.52% | 34,529,400 | |
| 1,414,538 | Institution | 2.15% | 29,478,972 | |
| 944,900 | Institution | 1.44% | 19,691,716 | |
| 866,045 | Institution | 1.32% | 18,048,378 | |
| 826,367 | Institution | 1.26% | 17,221,488 | |
| 768,848 | Institution | 1.17% | 16,022,792 | |
| 484,303 | Institution | 0.74% | 10,092,875 | |
| 345,560 | Institution | 0.53% | 7,201,470 | |
| 314,014 | Institution | 0.48% | 6,544,052 | |
| 275,000 | Institution | 0.42% | 5,731,000 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,371,353 | Institution | 2.09% | 27,276,211 | |
| 771,810 | Institution | 1.17% | 17,689,885 | |
| 741,539 | Institution | 1.13% | 16,595,643 | |
| 356,410 | Institution | 0.54% | 7,088,995 | |
| 270,508 | Institution | 0.41% | 6,053,969 | |
| 251,739 | Institution | 0.38% | 5,633,919 | |
| 154,904 | Institution | 0.24% | 3,081,041 | |
| 153,617 | Institution | 0.23% | 3,520,902 | |
| 137,822 | Institution | 0.21% | 3,158,880 | |
| 83,240 | Institution | 0.13% | 1,655,644 |
FAQ
Who Owns Bicara Therapeutics Inc. (BCAX)?
According to the latest TipRanks data, approximately 24.51% of the company's stock is held by institutional investors, 21.76% is held by insiders, and 32.70% is held by retail investors.
What percentage of Bicara Therapeutics Inc. (BCAX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 24.51% of Bicara Therapeutics Inc. (BCAX) stock is held by institutional investors.
What percentage of Bicara Therapeutics Inc. (BCAX) stock is held by retail investors?
According to the latest TipRanks data, approximately 32.70% of Bicara Therapeutics Inc. (BCAX) stock is held by retail investors.
Who owns the most shares of Bicara Therapeutics Inc. (BCAX)?
Peter Kolchinsky owns the most shares of Bicara Therapeutics Inc. (BCAX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.